Whole body functional MR imaging: hemato-oncologic applications

被引：5

作者：

Luciani, A. ^{[1
]}

Lin, C. ^{[1
]}

Beaussart, P. ^{[1
]}

Zerbib, P. ^{[1
]}

Haioun, C. ^{[2
]}

Rahmouni, A. ^{[1
]}

机构：

[1] Grp Hosp Henri Mondor Chenevier, AP HP, Serv Imagerie Med, Fac Med Paris 12, F-94010 Creteil, France

[2] Grp Hosp Henri Mondor Chenevier, AP HP, Serv Hematol, Fac Med Paris 12, F-94010 Creteil, France

来源：

JOURNAL DE RADIOLOGIE | 2010年 / 91卷 / 03期

关键词：

MRI; Functional MRI; Myeloma; Lymphoma; Diffusion; Contrast agent; BONE-MARROW ANGIOGENESIS; SUV-BASED ASSESSMENT; TURBO SPIN-ECHO; B-CELL LYMPHOMA; MULTIPLE-MYELOMA; PROGNOSTIC VALUE; SINGLE-SHOT; INITIAL-EXPERIENCE; STAGING SYSTEM; F-18-FDG PET;

D O I：

10.1016/S0221-0363(10)70053-6

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Hemato-oncologic imaging combines anatomical and functional imaging data for optimal staging and follow-up of patients. It is currently possible to achieve high spatial resolution and functional evaluation at whole body MR imaging. Functional imaging may be achieved with two techniques: dynamic imaging following intravenous contrast injection and diffusion-weighted imaging. The purpose of this article is to demonstrate how both functional imaging techniques can be combined with whole body MR imaging for the evaluation of multiple myeloma and lymphomas.

引用

页码：375 / 380

页数：6

共 50 条

[41] Clinical factors influencing both red cell and platelet transfusion frequency in hemato-oncologic patients
Van Den Bos, A. G.
Al Zaher, V.
Blijlevens, N. P.
Donnelly, J.
Novotny, V. M.
TRANSFUSION, 2006, 46 (09) : 155A - 155A
[42] Relative role of motion and PSF compensation in whole-body oncologic PET-MR imaging
Petibon, Yoann
Huang, Chuan
Ouyang, Jinsong
Reese, Timothy G.
Li, Quanzheng
Syrkina, Aleksandra
Chen, Yen-Lin
El Fakhri, Georges
MEDICAL PHYSICS, 2014, 41 (04)
[43] Whole-Body MR Imaging - Evolution and Current Clinical Applications PREFACE
Eustace, Stephen J.
SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2010, 14 (01) : 1 - 1
[44] Mesial Temporal Sclerosis as Late Consequence of Posterior Reversible Encephalopathy Syndrome in Pediatric Hemato-oncologic Patients
Faraci, Maura
Nobile, Giulia
Nobili, Lino
Masetti, Riccardo
Cordelli, Duccio
Toni, Francesco
Giardino, Stefano
Morana, Giovanni
Mancardi, Maria M.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (01) : E168 - E175
[45] Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors
Gueta, I.
Loebstein, R.
Markovits, N.
Kamari, Y.
Halkin, H.
Livni, G.
Yarden-Bilavsky, H.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (09) : 1181 - 1185
[46] Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors
I. Gueta
R. Loebstein
N. Markovits
Y. Kamari
H. Halkin
G. Livni
H. Yarden-Bilavsky
European Journal of Clinical Pharmacology, 2017, 73 : 1181 - 1185
[47] Mortality of Hemato-Oncologic Patients Admitted to a Pediatric Intensive Care Unit: A Single-Center Experience
Pechlaner, Agnes
Kropshofer, Gabriele
Crazzolara, Roman
Hetzer, Benjamin
Pechlaner, Raimund
Cortina, Gerard
FRONTIERS IN PEDIATRICS, 2022, 10
[48] Whole body MR imaging for tumor staging
Lauenstein, TC
Vogt, FM
Ruehm, SG
Herborn, CU
Debatin, JF
Barkhausen, J
RADIOLOGY, 2002, 225 : 269 - 270
[49] A Study of Discomfort and Bleeding According to Bedrest Time After Bone Marrow Examination in Pediatric Hemato-Oncologic Patient
Lee, H. Y.
PEDIATRIC BLOOD & CANCER, 2019, 66 : S441 - S442
[50] First Case of Pleural Empyema Caused by Aureimonas altamirensis: An Unusual Opportunistic Pathogen to be Aware of in Hemato-Oncologic Patients
Andreozzi, Fabio
Wittnebel, Sebastian
Yvette, Miendje
Lewalle, Philippe
Georgala, Aspasia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S213 - S214

← 1 2 3 4 5 →